Show simple item record

dc.contributor.authorHenaghan, Mark
dc.contributor.authorCleary, Thomas
dc.contributor.editorElliston, Sarah
dc.contributor.editorMcLean, Sheila A.M.
dc.date.available2018-11-29T22:08:58Z
dc.date.copyright2013
dc.identifier.citationMark Henaghan and Thomas Cleary "The state in action" in Sarah Elliston and Sheila A.M. McLean (eds) Regulating Pre-Implantation Genetic Diagnosis A Comparative and Theoretical Analysis (Taylor and Francis, Oxon, 2013) 199.en_NZ
dc.identifier.urihttp://hdl.handle.net/10523/8677
dc.description.abstractIn New Zealand the choice by intending parents to use reproductive technology is limited by legislation. This default restriction on the prospective parents’ procreative autonomy applies unless the use of the assisted reproductive procedure has been approved on the basis of guidelines or regulations. The task of creating these guidelines falls to a non-governmental advisory committee, the Advisory Committee on Assisted Reproductive Technology (ACART). This advisory committee is supposedly unconstrained by political considerations and, in theory, provides a forum for deliberative discussions on the ethical and social disagreements that surround the use of assisted reproductive technologies. This chapter provides an analysis, from the perspective of a member of ACART, of how the advisory committee functions in reality. It focuses specifically on the developments of guidelines controlling the use of pre-implantation genetic diagnosis (PGD) with human leukocyte antigen (HLA) tissue-typing, more commonly referred to as creating ‘saviour siblings’.en_NZ
dc.language.isoenen_NZ
dc.publisherTaylor and Francisen_NZ
dc.relation.ispartofegulating Pre-Implantation Genetic Diagnosis A Comparative and Theoretical Analysisen_NZ
dc.subjectNew Zealanden_NZ
dc.subjectPreimplantation Genetic Diagnosisen_NZ
dc.subjectHLA Tissue-Typingen_NZ
dc.subjectReproductive Technologiesen_NZ
dc.subjectHuman Assisted Reproductive Technology Act 2004en_NZ
dc.titleThe State in Action: An Insider's View of How the State Regulates the Use of PGD with HLA Tissue-Typing in New Zealanden_NZ
dc.typeChapter in Book
dc.date.updated2018-11-28T23:06:08Z
otago.schoolUniversity of Otago Faculty of Lawen_NZ
otago.openaccessAbstract Onlyen_NZ
 Find in your library

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item is not available in full-text via OUR Archive.

If you are the author of this item, please contact us if you wish to discuss making the full text publicly available.

This item appears in the following Collection(s)

Show simple item record